288 related articles for article (PubMed ID: 22935988)
1. Sigma-1R agonist improves motor function and motoneuron survival in ALS mice.
Mancuso R; Oliván S; Rando A; Casas C; Osta R; Navarro X
Neurotherapeutics; 2012 Oct; 9(4):814-26. PubMed ID: 22935988
[TBL] [Abstract][Full Text] [Related]
2. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?
Mancuso R; Del Valle J; Morell M; Pallás M; Osta R; Navarro X
Orphanet J Rare Dis; 2014 May; 9():78. PubMed ID: 24885036
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.
Mancuso R; del Valle J; Modol L; Martinez A; Granado-Serrano AB; Ramirez-Núñez O; Pallás M; Portero-Otin M; Osta R; Navarro X
Neurotherapeutics; 2014 Apr; 11(2):419-32. PubMed ID: 24414863
[TBL] [Abstract][Full Text] [Related]
5. EST79232 and EST79376, Two Novel Sigma-1 Receptor Ligands, Exert Neuroprotection on Models of Motoneuron Degeneration.
Gaja-Capdevila N; Hernández N; Yeste S; Reinoso RF; Burgueño J; Montero A; Merlos M; Vela JM; Herrando-Grabulosa M; Navarro X
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743175
[TBL] [Abstract][Full Text] [Related]
6. Bisperoxovanadium promotes motor neuron survival and neuromuscular innervation in amyotrophic lateral sclerosis.
Wang J; Tierney L; Mann R; Lonsway T; Walker CL
Mol Brain; 2021 Oct; 14(1):155. PubMed ID: 34635126
[TBL] [Abstract][Full Text] [Related]
7. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
8. Sigma receptor agonist 2-(4-morpholinethyl)1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes neuroprotection after root avulsion injury.
Penas C; Pascual-Font A; Mancuso R; Forés J; Casas C; Navarro X
J Neurotrauma; 2011 May; 28(5):831-40. PubMed ID: 21332255
[TBL] [Abstract][Full Text] [Related]
9. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
10. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models.
Ono Y; Tanaka H; Takata M; Nagahara Y; Noda Y; Tsuruma K; Shimazawa M; Hozumi I; Hara H
Neurosci Lett; 2014 Jan; 559():174-8. PubMed ID: 24334165
[TBL] [Abstract][Full Text] [Related]
11. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 Receptor in Motoneuron Disease.
Mancuso R; Navarro X
Adv Exp Med Biol; 2017; 964():235-254. PubMed ID: 28315275
[TBL] [Abstract][Full Text] [Related]
13. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis.
Korkmaz OT; Aytan N; Carreras I; Choi JK; Kowall NW; Jenkins BG; Dedeoglu A
Neurosci Lett; 2014 Apr; 566():286-91. PubMed ID: 24637017
[TBL] [Abstract][Full Text] [Related]
14. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
15. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1
Ionescu A; Gradus T; Altman T; Maimon R; Saraf Avraham N; Geva M; Hayden M; Perlson E
Cell Death Dis; 2019 Mar; 10(3):210. PubMed ID: 30824685
[TBL] [Abstract][Full Text] [Related]
17. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis.
Huang G; Lee X; Bian Y; Shao Z; Sheng G; Pepinsky RB; Mi S
Cell Death Dis; 2013 Oct; 4(10):e841. PubMed ID: 24113175
[TBL] [Abstract][Full Text] [Related]
18. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
[TBL] [Abstract][Full Text] [Related]
19. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis.
Jeon GS; Im W; Shim YM; Lee M; Kim MJ; Hong YH; Seong SY; Kim M; Sung JJ
Neurochem Res; 2016 Apr; 41(4):913-23. PubMed ID: 26646002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
